These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33563525)

  • 21. The safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysis.
    Tongsai S; Koomanachai P
    BMC Res Notes; 2016 Sep; 9(1):455. PubMed ID: 27686168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant
    Covvey JR; Erickson O; Fiumara D; Mazzei K; Moszczenski Z; Slipak K; Nemecek BD; Zimmerman DE; Guarascio AJ
    Ann Pharmacother; 2020 Jul; 54(7):644-651. PubMed ID: 31888350
    [No Abstract]   [Full Text] [Related]  

  • 23. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.
    Finch NA; Zasowski EJ; Murray KP; Mynatt RP; Zhao JJ; Yost R; Pogue JM; Rybak MJ
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy.
    Wong-Beringer A; Joo J; Tse E; Beringer P
    Int J Antimicrob Agents; 2011 Feb; 37(2):95-101. PubMed ID: 21130609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant
    Hirano R; Sakamoto Y; Kitazawa J; Yamamoto S; Tachibana N
    Infect Drug Resist; 2016; 9():243-252. PubMed ID: 27789965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
    Matson KL; Shaffer CL; Beck GL; Simonsen KA
    Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal vancomycin doses for methicillin-resistant Staphylococcus aureus infection in urological renal dysfunction patients.
    Shigemura K; Osawa K; Yamamichi F; Tanaka K; Tokimatsu I; Arakawa S; Fujisawa M
    Int Urol Nephrol; 2015 Jun; 47(6):887-91. PubMed ID: 25899764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention to age: similar dosing regimens lead to different vancomycin levels among older and younger patients.
    Yahav D; Abbas M; Nassar L; Ghrayeb A; Shepshelovich D; Kurnik D; Leibovici L; Paul M
    Age Ageing; 2019 Dec; 49(1):26-31. PubMed ID: 31711101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
    Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review and meta-analysis of the efficacy and safety of vancomycin combined with β-lactam antibiotics in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections.
    Ye C; Wang Z; Hu Y; Deng C; Liao L; Sun L; Wang C
    J Glob Antimicrob Resist; 2020 Dec; 23():303-310. PubMed ID: 33045437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin.
    Masuda N; Maiguma T; Komoto A; Haruki Y; Sugiyama T; Kondo S; Teshima D
    Int J Clin Pharmacol Ther; 2015 Apr; 53(4):284-91. PubMed ID: 25740266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin Area Under the Curve-Guided Dosing and Monitoring for Adult and Pediatric Patients With Suspected or Documented Serious Methicillin-Resistant Staphylococcus aureus Infections: Putting the Safety of Our Patients First.
    Lodise TP; Drusano G
    Clin Infect Dis; 2021 May; 72(9):1497-1501. PubMed ID: 33740042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review.
    Tkachuk S; Collins K; Ensom MHH
    Paediatr Drugs; 2018 Apr; 20(2):153-164. PubMed ID: 29344778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of vancomycin dosing and corresponding drug concentrations in pediatric patients.
    Geerlof LM; Boucher J
    Hosp Pediatr; 2014 Nov; 4(6):342-7. PubMed ID: 25362075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric pharmaceutical care with anti-infective medication in a patient with acute hematogenous osteomyelitis caused by methicillin-resistant
    Lv C; Lv J; Liu Y; Liu Q; Zou D
    Int J Immunopathol Pharmacol; 2020; 34():2058738420925713. PubMed ID: 32567423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China.
    Dong MH; Wang JW; Wu Y; Chen BY; Yu M; Wen AD
    Int J Infect Dis; 2015 Aug; 37():125-8. PubMed ID: 26159843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome.
    McNeil JC; Kok EY; Forbes AR; Lamberth L; Hulten KG; Vallejo JG; Mason EO; Kaplan SL
    Pediatr Infect Dis J; 2016 Mar; 35(3):263-8. PubMed ID: 26646549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
    Prybylski JP
    Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
    Bounthavong M; Hsu DI
    Curr Med Res Opin; 2010 Feb; 26(2):407-21. PubMed ID: 20001574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.